RecruitingNot ApplicableNCT04485897

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?


Sponsor

Luzerner Kantonsspital

Enrollment

25 participants

Start Date

Nov 26, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure. Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard. The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares two methods of monitoring eye pressure (intraocular pressure) in glaucoma patients: self-monitoring at home using a handheld device versus the traditional method of multiple measurements taken at the hospital over the course of a day. The goal is to determine if home monitoring is accurate enough to guide treatment. **You may be eligible if...** - You are 18 or older with glaucoma, or you are a healthy control participant - You have adequate vision and corneal thickness within normal range - Your glaucoma treatment has been stable for at least 30 days - You have passed a certification test to use the self-monitoring device correctly **You may NOT be eligible if...** - You have had eye trauma or have a corneal condition like keratoconus - You have dry eye disease or a physical disability that prevents self-measurement - You have Parkinson's disease or arthritis that would prevent accurate self-testing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEicare HOME device (Icare Oy, Vanda, Finland)

icare HOME device versus hospital based measurements


Locations(1)

Cantonal Hospital of Lucerne

Lucerne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04485897


Related Trials